SUMMARY

 

This year, we present the first annual update to the estimates of FP2020’s Core Indicators—the quantitative metrics we use to measure progress across the 69 FP2020 focus countries.[53]

 

Complete tables of the Core Indicator estimates and sources are found in the Annex. During the first year of FP2020’s operation we see evidence of progress in enabling more women and girls to use modern methods of contraception.[54] We also observe persistent challenges in delivering method choice and equitable outcomes, especially for vulnerable populations. The data are encouraging, but it is clear that we must accelerate our efforts if we are to meet our goal.[55]

 

OUR TOPLINE FINDINGS ARE:

 

  • In 2013, 8.4 million additional women and girls were using modern contraception compared to 2012 across the 69 FP2020 focus countries.
  • In 2013, across the 69 FP2020 focus countries, the use of modern contraceptives by 274 million [56] women and girls of reproductive age averted 77 million unintended pregnancies, which amounts to 2 million more unintended pregnancies averted compared to 2012.
  • Averting 77 million unintended pregnancies created substantial health impacts by reducing women’s exposure to unsafe abortions and maternal deaths. In 2013, there were 24 million unsafe abortions averted (compared to 23 million in 2012) and 125,000 maternal deaths averted (compared to 120,000 in 2012) across the 69 FP2020 countries.
  • The percentage of women and girls of reproductive age using modern methods of contraception—the modern contraceptive prevalence rate (mCPR)—averaged 23.5% across the 69 FP2020 focus countries. In 12 countries mCPR was greater than 40%; in nearly half (32) of the countries, mCPR was less than 20%.
  • The average annual rate of mCPR growth was marginally lower in 2013 (0.65%) than reported in 2012 (0.73%). Some countries had new data that showed they experienced slower or static mCPR growth rates despite expanding their family programs to serve many more women and girls. This can occur when the growth of the population of women and girls of reproductive age outpaces program expansion.
  • The average mCPR growth rate across all countries masks some important shifts, such as countries where the growth trajectory is rising. In Bhutan, Djibouti, Ethiopia, Kenya and Rwanda, growth rates exceeded 2.5%.
  • Dominance by a single method of modern contraception is a defining feature in more than half of the FP2020 focus countries. In DR Congo, Ethiopia and India, more than 60% of users rely on a single method.
  • There was little change in the levels of unmet need and demand satisfied for modern methods of contraception. This is unsurprising given the short window of observation and the potential for efforts to increase demand to also increase levels of unmet need. It was assumed that progress would be slowest in the first year of the FP2020 initiative and that demand for contraception might grow more rapidly than access to services.
  • Among women and girls of reproductive age who are married or in union, the level of unmet need is higher for the 15 to 19 age group than it is overall.

 

 

 

 

Interactive Map: Explore Key Family Planning Data

 

Figure 4.1

ADDITIONAL USERS OF MODERN METHODS OF CONTRACEPTION BY REGION, 2012-2013

Numbers are rounded.

South Africa not included in regional total.

HOVER TO EXLORE DATA

TOTAL ADDITIONAL USERS OF MODERN METHODS OF CONTRACEPTION IN FP2020 FOCUS COUNTRIES

8,400,000

Figure 4.6

ANNUAL GROWTH RATES IN mCPR

HOVER TO EXLORE DATA
  • < 0
  • 1.5-2.0
  • 0-0.5
  • 2.0-2.5
  • 0.5-1.0
  • > 2.5
  • 1.0-1.5

Figure 4.9

mCPR DISAGGREGATED BY RELATIVE WEALTH AND RESIDENCE

HOVER TO EXLORE DATA

Figure 4.14

INDICATOR 3: PERCENTAGE OF WOMEN WITH AN UNMET NEED FOR MODERN CONTRACEPTION, 2013

HOVER TO EXLORE DATA

COUNTRIES IN WHICH THE PERCENTAGE OF WOMEN WITH AN UNMET NEED FOR MODERN CONTRACEPTION IS

  • < 15%
  • 15-30%
  • > 30%

 

 

 

Download Full Progress Report

 

 


53. Countries with a GNI per capita equal to or less than $2,500 (2010).


54. Modern methods include pill, injectables, IUD, implants, male and female condoms, LAM, diaphragm, foam/jelly, female and male sterilization, and the Standard Days Method.


55. All findings are for 2013, across the 69 FP2020 focus countries except where noted.